查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1772237

全球多體學服務市場：市場規模、佔有率、趨勢分析（按服務、類型、應用、最終用途和地區）、細分市場預測（2025-2033）

Multiomics Services Market Size, Share & Trends Analysis Report By Service (Research, Data Analysis), By Type (Single-cell Multiomics, Bulk Multiomics), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

多組體學服務市場成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球多組體學服務市場預計到2033年將達到47.2億美元，2025年至2033年期間的複合年成長率為17.41%。

多體學服務產業正經歷加速成長，這得益於對整合生物數據日益成長的需求，這些數據旨在實現精準醫療、高階診斷和系統生物學研究。隨著對複雜生物機制理解需求的不斷成長，結合基因組學、轉錄組學、蛋白質組學、代謝體學和表觀基因的多組體學正成為全面發現生物標記、疾病分層和開發療法的重要工具。

製藥和生物技術公司、研究機構和臨床實驗室擴大利用多體學平台來深入了解疾病路徑、治療標靶和患者特異性反應。策略聯盟、不斷增加的研發投入以及技術融合正在推動多組體學服務的創新，同時提高跨組體學層面的數據整合和可解釋性。

多組體學在腫瘤學、免疫學、神經病學和感染疾病研究中的應用日益廣泛，進一步推動了市場擴張。在資料品質、隱私和臨床檢驗法律規範日益嚴格的背景下，服務供應商正在投資強大的品管系統、安全的資料管理解決方案和人工智慧主導的分析技術，以滿足不斷變化的客戶和合規性需求。多體學服務透過提供對生物系統和疾病進展的整體情況，正在重塑轉化醫學和個人化醫療的未來。

隨著體學技術的快速發展和對精準洞察的需求不斷成長，多體學服務市場有望成為下一代生物醫學創新和全球健康轉型的基石。

多組體學服務市場：分析概述

  • 預計研究服務領域將在2024年佔據最大的市場收益佔有率。這一領先地位源於其在支持臨床前試驗、機制研究和早期藥物發現方面發揮的重要作用。隨著多體學方法成為理解複雜疾病生物學的關鍵，學術和商業性研究的需求只會不斷成長。
  • 由於大量多體學學在大規模研究中的廣泛應用，以及基因組學、轉錄組學和蛋白質組學領域已建立的工作流程，預計批量多組學將在2024年佔據最大的市場收益佔有率。這些方法廣泛應用於群體層級的生物標記發現、疾病分析和標靶驗證。單細胞定序技術的進步持續推動其在腫瘤學、免疫學和神經科學研究領域的應用。
  • 受對整合資料日益成長的需求推動，藥物發現和開發領域旨在加速目標識別和簡化研發流程，該領域在 2024 年佔據市場最大收入佔有率，達到 35.45%。然而，合成生物學領域預計將以最快的速度成長，預測期內的複合年成長率為 19.40%。
  • 2024年，製藥和生物技術領域佔據了最大的市場收益佔有率。這些機構正在將多組體學納入其研發工作流程，以加速精準藥物開發、伴隨委外研發機構和療法最佳化。與合約研究組織（CRO）和多組體學平台提供者日益增多的合作也為此領域提供了支持。
  • 北美佔據市場主導地位，2024年其收益佔有率最高，達到40.13%，這得益於其先進的醫療基礎設施、雄厚的基因組學研究資金以及體學技術的早期應用。然而，預計亞太地區在預測期內的複合年成長率最高，達19.62%。
  • 2025年1月，NVIDIA宣布與IQVIA、Illumina、梅奧診所和Ark Research Institute建立策略夥伴關係，以徹底改變基因組學、藥物研發和醫療保健領域。這些合作將專注於開發用於加速臨床試驗的AI代理、用於藥物研發和數位病理學的AI模型，以及用於手術和病患監測的實體AI機器人。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章 市場促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 多組體學服務市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章 多體學服務市場：按服務分類的業務分析

  • 細分儀表板：依服務
  • 全球多組體學服務市場：變異分析（按服務）
  • 全球多組體學服務市場規模及趨勢分析（按服務分類）（2021-2033）
  • 研究服務
  • 數據分析服務

第5章多體學服務市場：按類型分類的業務分析

  • 細分儀表板：按類型
  • 全球多體學服務市場：變異分析（按類型）
  • 全球多組體學服務市場規模及趨勢分析（按類型）（2021-2033）
  • 單細胞多組體學
  • 批量體學

第6章多組體學服務市場：按應用進行的業務分析

  • 細分儀表板：依用途
  • 全球多體學服務市場：變異分析（按應用）
  • 全球多體學服務市場規模與應用趨勢分析（2021-2033）
  • 生物標記發現
  • 藥物研發
  • 合成生物學
  • 其他

7. 多組體學服務市場：依最終用途進行的業務分析

  • 細分儀表板：依最終用途
  • 全球多體學服務市場（按變異分析和最終用途）
  • 全球多組體學服務市場規模和趨勢分析（按最終用途）（2021-2033）
  • 製藥和生物技術公司
  • 學術研究所
  • 其他

第8章 多組體學服務市場：按地區估計和趨勢分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 公司分類
  • 戰略地圖
  • 企業市場分析（2024年）
  • 公司簡介/上市公司
    • Bio-Techne
    • CD Genomics
    • RayBiotech, Inc.
    • . Creative Proteomics
    • Psomagen
    • Source BioScience
    • Persistent Systems
    • Metware Biotechnology Inc.
    • Dalton Bioanalytics Inc.
    • Sapient Bioanalytics, LLC.
Product Code: GVR-4-68040-640-2

Multiomics Services Market Growth & Trends:

The global multiomics services market size is projected to reach USD 4.72 billion by 2033, growing at a CAGR of 17.41% from 2025 to 2033, according to a new report by Grand View Research, Inc. The multiomics services industry is witnessing accelerated growth, driven by the increasing demand for integrated biological data to enable precision medicine, advanced diagnostics, and systems biology research. As the need to understand complex biological mechanisms intensifies, multiomics approaches combining genomics, transcriptomics, proteomics, metabolomics, and epigenomics are becoming essential tools for comprehensive biomarker discovery, disease stratification, and therapeutic development.

Pharmaceutical and biotechnology companies, research institutions, and clinical laboratories increasingly leverage multiomics platforms to gain deeper insights into disease pathways, therapeutic targets, and patient-specific responses. Strategic collaborations, rising R&D investments, and technological convergence catalyze innovation in multiomics service offerings while enhancing data integration and interpretability across diverse omics layers.

The growing adoption of multiomics in oncology, immunology, neurology, and infectious disease research further fueled the market's expansion. As regulatory frameworks around data quality, privacy, and clinical validation tighten, service providers invest in robust quality control systems, secure data management solutions, and AI-driven analytics to meet evolving customer and compliance needs. Multiomics services are reshaping the future of translational medicine and individualized healthcare by offering holistic views of biological systems and disease progression.

With the rapid evolution of omics technologies and the growing demand for precision insights, the multiomics services market is positioned to become a cornerstone of next-generation biomedical innovation and global health transformation.

Multiomics Services Market Report Highlights:

  • The research services segment accounted for the largest market revenue share in 2024. This leadership derives from their foundational role in supporting preclinical studies, mechanistic research, and early-stage drug discovery. As multiomics approaches become integral to understanding complex disease biology, academic and commercial research demand continues to rise.
  • The bulk multiomics segment accounted for the largest market revenue share in 2024, owing to its widespread adoption in large-scale studies and established workflows in genomics, transcriptomics, and proteomics. These approaches are widely used in population-level biomarker discovery, disease profiling, and target validation. Advances in single cell sequencing technologies continue to drive adoption across oncology, immunology, and neuroscience research.
  • The drug discovery & development segment led the market with the largest revenue share of 35.45% in 2024, driven by the growing need for integrated data to accelerate target identification and streamline R&D. However, the synthetic biology segment is expected to grow at the fastest CAGR of 19.40% over the forecast period.
  • The pharmaceutical and biotechnology segment accounted for the largest market revenue share in 2024. These organizations integrate multiomics into R&D workflows to accelerate precision drug development, companion diagnostics, and therapeutic optimization. Increasing collaborations with contract research organizations (CROs) and multiomics platform providers support this segment.
  • North America dominated the market with the largest revenue share of 40.13% in 2024. This is attributed to advanced healthcare infrastructure, strong genomics research funding, and early adoption of omics technologies. However, Asia Pacific is expected to grow at the highest CAGR of 19.62% over the forecast period.
  • In January 2025, NVIDIA announced strategic partnerships with IQVIA, Illumina, Mayo Clinic, and Arc Institute to revolutionize genomics, drug discovery, and healthcare. The initiatives focus on developing AI agents to expedite clinical trials, AI models for drug discovery and digital pathology, and physical AI robots for surgery and patient monitoring.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Service Segment
    • 1.2.2. Type Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Multiomics Services Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Multiomics Services Market: Service Business Analysis

  • 4.1. Service Segment Dashboard
  • 4.2. Global Multiomics Services Market Service Movement Analysis
  • 4.3. Global Multiomics Services Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 4.4. Research Services
    • 4.4.1. Global Research Services based Market, 2021 - 2033 (USD Million)
  • 4.5. Data Analysis Services
    • 4.5.1. Global Data Analysis Services Market, 2021 - 2033 (USD Million)

Chapter 5. Multiomics Services Market: Type Business Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. Global Multiomics Services Market Type Movement Analysis
  • 5.3. Global Multiomics Services Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 5.4. Single-cell Multiomics
    • 5.4.1. Global Single-cell Multiomics Market, 2021 - 2033 (USD Million)
  • 5.5. Bulk Multiomics
    • 5.5.1. Global Bulk Multiomics Market, 2021 - 2033 (USD Million)

Chapter 6. Multiomics Services Market: Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global Multiomics Services Market Application Movement Analysis
  • 6.3. Global Multiomics Services Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Biomarker Discovery Market
    • 6.4.1. Global Biomarker Discovery Market, 2021 - 2033 (USD Million)
  • 6.5. Drug Discovery & Development
    • 6.5.1. Global Drug Discovery & Development Market, 2021 - 2033 (USD Million)
  • 6.6. Synthetic Biology
    • 6.6.1. Global Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Others Market, 2021 - 2033 (USD Million)

Chapter 7. Multiomics Services Market: End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global Multiomics Services Market End Use Movement Analysis
  • 7.3. Global Multiomics Services Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Pharmaceutical and Biotechnology Companies
    • 7.4.1. Global Pharmaceutical and Biotechnology Companies Devices Market, 2021 - 2033 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Global Academic & Research Institutes Market, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Multiomics Services Market: Region Estimates & Trend Analysis

  • 8.1. North America
    • 8.1.1. North America market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.1.2. U.S.
      • 8.1.2.1. Key country dynamics
      • 8.1.2.2. Competitive scenario
      • 8.1.2.3. Regulatory Framework
      • 8.1.2.4. Target Disease Prevalence
      • 8.1.2.5. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.1.3. Canada
      • 8.1.3.1. Key country dynamics
      • 8.1.3.2. Competitive scenario
      • 8.1.3.3. Regulatory Framework
      • 8.1.3.4. Target Disease Prevalence
      • 8.1.3.5. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.1.4. Mexico
      • 8.1.4.1. Key country dynamics
      • 8.1.4.2. Competitive scenario
      • 8.1.4.3. Regulatory Framework
      • 8.1.4.4. Target Disease Prevalence
      • 8.1.4.5. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.2. Europe
    • 8.2.1. Europe market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.2. UK
      • 8.2.2.1. Key country dynamics
      • 8.2.2.2. Competitive scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Target Disease Prevalence
      • 8.2.2.5. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.3. Germany
      • 8.2.3.1. Key country dynamics
      • 8.2.3.2. Competitive scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Target Disease Prevalence
      • 8.2.3.5. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.4. France
      • 8.2.4.1. Key country dynamics
      • 8.2.4.2. Competitive scenario
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Target Disease Prevalence
      • 8.2.4.5. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.5. Italy
      • 8.2.5.1. Key country dynamics
      • 8.2.5.2. Competitive scenario
      • 8.2.5.3. Regulatory Framework
      • 8.2.5.4. Target Disease Prevalence
      • 8.2.5.5. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.6. Spain
      • 8.2.6.1. Key country dynamics
      • 8.2.6.2. Competitive scenario
      • 8.2.6.3. Regulatory Framework
      • 8.2.6.4. Target Disease Prevalence
      • 8.2.6.5. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.7. Norway
      • 8.2.7.1. Key country dynamics
      • 8.2.7.2. Competitive scenario
      • 8.2.7.3. Regulatory Framework
      • 8.2.7.4. Target Disease Prevalence
      • 8.2.7.5. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.8. Sweden
      • 8.2.8.1. Key country dynamics
      • 8.2.8.2. Competitive scenario
      • 8.2.8.3. Regulatory Framework
      • 8.2.8.4. Target Disease Prevalence
      • 8.2.8.5. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.9. Denmark
      • 8.2.9.1. Key country dynamics
      • 8.2.9.2. Competitive scenario
      • 8.2.9.3. Regulatory Framework
      • 8.2.9.4. Target Disease Prevalence
      • 8.2.9.5. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3. Asia Pacific
    • 8.3.1. Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. Japan
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Target Disease Prevalence
      • 8.3.2.5. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. China
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Target Disease Prevalence
      • 8.3.3.5. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. India
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Target Disease Prevalence
      • 8.3.4.5. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.5. Thailand
      • 8.3.5.1. Key country dynamics
      • 8.3.5.2. Competitive scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Target Disease Prevalence
      • 8.3.5.5. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.6. South Korea
      • 8.3.6.1. Key country dynamics
      • 8.3.6.2. Competitive scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Target Disease Prevalence
      • 8.3.6.5. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.7. Australia
      • 8.3.7.1. Key country dynamics
      • 8.3.7.2. Competitive scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Target Disease Prevalence
      • 8.3.7.5. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Latin America
    • 8.4.1. Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Brazil
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Target Disease Prevalence
      • 8.4.2.5. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Argentina
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Middle East & Africa
    • 8.5.1. Middle East & Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. South Africa
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Target Disease Prevalence
      • 8.5.2.5. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Saudi Arabia
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. UAE
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Kuwait
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Target Disease Prevalence
      • 8.5.5.5. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Bio-Techne
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Service Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. CD Genomics
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Service Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. RayBiotech, Inc.
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Service Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. . Creative Proteomics
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Service Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Psomagen
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Service Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Source BioScience
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Service Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Persistent Systems
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Service Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Metware Biotechnology Inc.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Service Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Dalton Bioanalytics Inc.
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Service Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Sapient Bioanalytics, LLC.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Service Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 North America multiomics services market estimates & forecasts
  • Table 2 North America multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 3 North America multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 4 North America multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 5 North America multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 7 U.S. multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 8 U.S. multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 9 U.S. multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 10 Canada multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 11 Canada multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 12 Canada multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 13 Canada multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 14 Mexico multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 15 Mexico multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 16 Mexico multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 17 Mexico multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 18 Europe multiomics services market estimates & forecasts
  • Table 19 Europe multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 20 Europe multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 21 Europe multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 22 Europe multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 24 UK multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 25 UK multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 26 UK multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 27 Germany multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 28 Germany multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 29 Germany multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 30 Germany multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 31 France multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 32 France multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 33 France multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 34 France multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 36 Spain multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 37 Spain multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 38 Spain multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 39 Italy multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 40 Italy multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 41 Italy multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 42 Italy multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 43 Denmark multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 44 Denmark multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 45 Denmark multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 46 Denmark multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 47 Sweden multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 48 Sweden multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 49 Sweden multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 50 Sweden multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 51 Norway multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 52 Norway multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 53 Norway multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 54 Norway multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 55 Asia Pacific multiomics services market estimates & forecasts
  • Table 56 Asia Pacific multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 60 China multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 61 China multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 62 China multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 63 China multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 64 Japan multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 65 Japan multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 66 Japan multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 67 Japan multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 68 India multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 69 India multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 70 India multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 71 India multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 72 South Korea multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 73 South Korea multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 74 South Korea multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 75 South Korea multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 76 Australia multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 77 Australia multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 78 Australia multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 79 Australia multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 80 Thailand multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 81 Thailand multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 82 Thailand multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 83 Thailand multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 84 Latin America multiomics services market estimates & forecasts
  • Table 85 Latin America multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 86 Latin America multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 87 Latin America multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 88 Latin America multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 89 Brazil multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 90 Brazil multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 91 Brazil multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 92 Brazil multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 93 Argentina multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 94 Argentina multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 95 Argentina multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 96 Argentina multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 97 MEA multiomics services market estimates & forecasts
  • Table 98 MEA multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 99 MEA multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 100 MEA multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 101 MEA multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 102 South Africa multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 103 South Africa multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 104 South Africa multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 105 South Africa multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 106 Saudi Arabia multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 110 UAE multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 111 UAE multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 112 UAE multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 113 UAE multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 114 Kuwait multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 115 Kuwait multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 116 Kuwait multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 117 Kuwait multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market snapshot
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market trends & outlook
  • Fig. 7 Market segmentation & scope
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 PESTLE Analysis
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Strategy framework
  • Fig. 13 Participant categorization
  • Fig. 14 Multiomics Services market: Service outlook key takeaways
  • Fig. 15 Multiomics Services market: Service movement analysis
  • Fig. 16 Research Services market, 2021 - 2033 (USD million)
  • Fig. 17 Data Analysis Services market, 2021 - 2033 (USD million)
  • Fig. 18 Multiomics Services market: Type outlook key takeaways
  • Fig. 19 Multiomics Services market: Type movement analysis
  • Fig. 20 Single-cell Multiomics market, 2021 - 2033 (USD million)
  • Fig. 21 Bulk Multiomics market, 2021 - 2033 (USD million)
  • Fig. 22 Multiomics Services market: Application outlook key takeaways
  • Fig. 23 Multiomics Services market: Application movement analysis
  • Fig. 24 Biomarker Discovery market, 2021 - 2033 (USD million)
  • Fig. 25 Drug Discovery & Development market, 2021 - 2033 (USD million)
  • Fig. 26 Synthetic Biology market, 2021 - 2033 (USD million)
  • Fig. 27 Others market, 2021 - 2033 (USD million)
  • Fig. 28 Multiomics Services market: End Use outlook key takeaways
  • Fig. 29 Multiomics Services market: End Use movement analysis
  • Fig. 30 Academic & Research Institutes market, 2021 - 2033 (USD Million)
  • Fig. 31 Pharmaceutical and Biotechnology Companies market, 2021 - 2033 (USD Million)
  • Fig. 32 Others market, 2021 - 2033 (USD Million)
  • Fig. 33 Multiomics Services market, by region, 2021 - 2033 (USD Million)
  • Fig. 34 North America multiomics services market, by country, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 36 Canada multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 37 Mexico multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 38 Europe multiomics services market, by country, 2021 - 2033 (USD Million)
  • Fig. 39 UK multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 40 Germany multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 41 France multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 42 Italy multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 43 Spain multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 44 Denmark multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 45 Sweden multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 46 Norway multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 47 Asia Pacific multiomics services market, by country, 2021 - 2033 (USD Million)
  • Fig. 48 Japan multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 49 China multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 50 India multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 51 Australia multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 52 South Korea multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 53 Thailand multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 54 Latin America multiomics services market, by country, 2021 - 2033 (USD Million)
  • Fig. 55 Brazil multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 56 Argentina multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 57 Middle East & Africa multiomics services market, by country, 2021 - 2033 (USD Million)
  • Fig. 58 South Africa multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 59 Saudi Arabia multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 60 UAE multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 61 Kuwait multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 62 Key companies profiled